These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33428271)

  • 1. Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long-term results and clinical outcomes.
    Castagno D; Di Donna P; Olivotto I; Frontera A; Calò L; Scaglione M; Arretini A; Anselmino M; Giustetto C; De Ferrari GM; Cecchi F; Haissaguerre M; Gaita F
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):657-666. PubMed ID: 33428271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.
    Di Donna P; Olivotto I; Delcrè SD; Caponi D; Scaglione M; Nault I; Montefusco A; Girolami F; Cecchi F; Haissaguerre M; Gaita F
    Europace; 2010 Mar; 12(3):347-55. PubMed ID: 20173211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Gaita F; Di Donna P; Olivotto I; Scaglione M; Ferrero I; Montefusco A; Caponi D; Conte MR; Nistri S; Cecchi F
    Am J Cardiol; 2007 Jun; 99(11):1575-81. PubMed ID: 17531584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.
    Creta A; Elliott P; Earley MJ; Dhinoja M; Finlay M; Sporton S; Chow A; Hunter RJ; Papageorgiou N; Lowe M; Mohiddin SA; Boveda S; Adragao P; Jebberi Z; Matos D; Schilling RJ; Lambiase PD; Providência R
    Europace; 2021 Sep; 23(9):1409-1417. PubMed ID: 33930121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term Outcome.
    Dinshaw L; Münkler P; Schäffer B; Klatt N; Jungen C; Dickow J; Tamenang A; Schleberger R; Pecha S; Pinnschmidt H; Patten M; Reichenspurner H; Willems S; Meyer C
    J Am Heart Assoc; 2021 Feb; 10(3):e017451. PubMed ID: 33455428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†.
    Lapenna E; Pozzoli A; De Bonis M; La Canna G; Nisi T; Nascimbene S; Vicentini L; Di Sanzo S; Del Forno B; Schiavi D; Alfieri O
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1112-1118. PubMed ID: 28329110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Zheng S; Jiang W; Dai J; Li K; Shi H; Wu W; Liu X; He B; Qiu X; Song Z
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):621-628. PubMed ID: 31930545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Providencia R; Elliott P; Patel K; McCready J; Babu G; Srinivasan N; Bronis K; Papageorgiou N; Chow A; Rowland E; Lowe M; Segal OR; Lambiase PD
    Heart; 2016 Oct; 102(19):1533-43. PubMed ID: 27234160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Zhao DS; Shen Y; Zhang Q; Lin G; Lu YH; Chen BT; Shi LS; Huang JF; Lu HH
    Europace; 2016 Apr; 18(4):508-20. PubMed ID: 26612881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Cryoballoon Ablation in Hypertrophic Cardiomyopathy-related Heart Failure due to Paroxysmal Atrial Fibrillation. A Comparative Case Series.
    Maagh P; Plehn G; Christoph A; Oernek A; Meissner A
    Int J Med Sci; 2016; 13(9):664-72. PubMed ID: 27647995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
    Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of catheter ablation of atrial fibrillation in hypertrophied hearts - Comparison between primary and secondary hypertrophy.
    Müssigbrodt A; Kosiuk J; Koutalas E; Pastromas S; Dagres N; Darma A; Lucas J; Breithardt OA; Sommer P; Dinov B; Eitel C; Rolf S; Döring M; Richter S; Arya A; Husser D; Bollmann A; Hindricks G
    J Cardiol; 2015 Jun; 65(6):474-8. PubMed ID: 25113952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
    Santangeli P; Di Biase L; Themistoclakis S; Raviele A; Schweikert RA; Lakkireddy D; Mohanty P; Bai R; Mohanty S; Pump A; Beheiry S; Hongo R; Sanchez JE; Gallinghouse GJ; Horton R; Dello Russo A; Casella M; Fassini G; Elayi CS; Burkhardt JD; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1089-94. PubMed ID: 24114776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial emptying fraction predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
    Chou CC; Lee HL; Chang PC; Wo HT; Wen MS; Yeh SJ; Lin FC; Hwang YT
    PLoS One; 2018; 13(1):e0191196. PubMed ID: 29364912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy.
    Roh SY; Kim DH; Ahn J; Lee KN; Lee DI; Shim J; Choi JI; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):788-95. PubMed ID: 27062657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ; Munger TM; Friedman PA; Asirvatham SJ; Brady PA; Cha YM; Rea RF; Shen WK; Powell BD; Ommen SR; Monahan KH; Haroldson JM; Packer DL
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1009-14. PubMed ID: 18479329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic and Health Value of Delaying Atrial Fibrillation Progression Using Radiofrequency Catheter Ablation.
    Berman AE; Kabiri M; Wei T; Galvain T; Sha Q; Kuck KH
    Circ Arrhythm Electrophysiol; 2023 Apr; 16(4):e011237. PubMed ID: 36891899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.